WHO ICTRP trial

A randomised controlled trial to compare withdrawal of therapy versus continuing…

EUCTR2012-003736-23-GB · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2012-003736-23-GB
Public title A randomised controlled trial to compare withdrawal of therapy versus continuing therapy in low disease states in psoriatic arthritis – feasibility study
Scientific title RETREAT(F) (REmoval of Treatment for patients in REmission in psoriatic ArThritis – Feasibility study). A randomised controlled trial to compare withdrawal of therapy versus continuing therapy in low disease states in psoriatic arthritis – feasibility study, RCT Arm - RETREAT(F) RCT Arm
Primary sponsor University of Leeds
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries United Kingdom
Conditions psoriatic arthritis;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Interventions Trade Name: Methotrexate Product Name: methotrexate po Pharmaceutical Form: Tablet INN or Proposed INN: methotrexate Trade Name: Salazopyrin En-Tabs Product Name: salazopyrin EN Pharmaceutical Form: Tablet INN or Proposed INN…
Registration date Apr 12, 2012
Target size 30
Secondary IDs RR11/9229
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations